MHS, Johns Hopkins School of Public Health, 2001
Ph.D., Johns Hopkins School of Medicine, 2005


Dr. Mulle has had a lifelong interest in the genetic etiology of schizophrenia, motivated by her own family history. Originally from Long Island, New York, she completed her undergraduate degree in biology at Johns Hopkins University.  She then earned her MPH with a concentration in genetic epidemiology from the Johns Hopkins School of Public Health. She went on to complete her PhD in Human Genetics at the Johns Hopkins School of Medicine. After a post-doctoral fellowship with Dr. Stephen Warren at Emory University, she joined the faculty at Emory and was there until 2021 when she accepted a position at CABM with an appointment in the Department of Psychiatry.  

Dr. Mulle loves her husband and children, her dogs, her research program, and Beyonce, in that order.  She currently has three large cow-shaped dogs, which is both too many and not enough

Research Focus

Research program employs a variety of modalities, including animal models, human cellular models, and clinical phenotyping studies, to understand the behavioral and biological impact of the 3q29 deletion
Russo R, Gambello M, Murphy M, et al. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care. Genetics in medicine : official journal of the American College of Medical Genetics. 2021;23(5):872-880. doi:10.1038/s41436-020-01053-1.
Sefik E, Purcell R, Project E, Walker E, Bassell G, Mulle J. Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome. Translational psychiatry. 2021;11(1):357. doi:10.1038/s41398-021-01435-2.
Pollak R, Murphy M, Epstein M, et al. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry. Molecular autism. 2019;10:30. doi:10.1186/s13229-019-0281-5.